DBV Technologies
DBV TECHNOLOGIES · public limited company with a board of directors (n.o.s.)
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 70 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 64 % · cci-v1
12 active sensors·3 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-13
Compare DBV Technologies with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies